Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738696 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine in Rotator Cuff Repair
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT03738696 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 64 participants.
The verdict
NCT03738696, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.
Interventions
- DRUG Exparel
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03738696
The ClinicalTrials.gov registry entry for NCT03738696 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT03738696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03738696 about?
NCT03738696 is a clinical study titled "Liposomal Bupivacaine in Rotator Cuff Repair". To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.
What is the current status of trial NCT03738696?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2019-12-15. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT03738696?
The interventions under investigation include: Exparel (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT03738696?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.